Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Receivables - Other: 2011-2015

Historic Receivables - Other for Northwest Biotherapeutics (NWBO) over the last 2 years, with Dec 2015 value amounting to $1.2 million.

  • Northwest Biotherapeutics' Receivables - Other fell 41.67% to $700,000 in Q3 2016 from the same period last year, while for Sep 2016 it was $700,000, marking a year-over-year decrease of 41.67%. This contributed to the annual value of $1.2 million for FY2015, which is N/A change from last year.
  • As of FY2015, Northwest Biotherapeutics' Receivables - Other stood at $1.2 million, which was up 100.00% from $600,000 recorded in FY2011.
  • In the past 5 years, Northwest Biotherapeutics' Receivables - Other registered a high of $1.2 million during FY2015, and its lowest value of $600,000 during FY2011.
  • Moreover, its 1-year median value for Receivables - Other was $1.2 million (2015), whereas its average is $1.2 million.